BE897356A - Compositions analgestiques et anti-inflammatoires - Google Patents

Compositions analgestiques et anti-inflammatoires Download PDF

Info

Publication number
BE897356A
BE897356A BE0/211220A BE211220A BE897356A BE 897356 A BE897356 A BE 897356A BE 0/211220 A BE0/211220 A BE 0/211220A BE 211220 A BE211220 A BE 211220A BE 897356 A BE897356 A BE 897356A
Authority
BE
Belgium
Prior art keywords
sep
analgesic
pharmaceutical compositions
caffeine
compositions according
Prior art date
Application number
BE0/211220A
Other languages
English (en)
French (fr)
Inventor
A Sunshine
E M Laska
C E Siegel
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of BE897356A publication Critical patent/BE897356A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BE0/211220A 1982-07-22 1983-07-22 Compositions analgestiques et anti-inflammatoires BE897356A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40059782A 1982-07-22 1982-07-22

Publications (1)

Publication Number Publication Date
BE897356A true BE897356A (fr) 1983-11-14

Family

ID=23584242

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/211220A BE897356A (fr) 1982-07-22 1983-07-22 Compositions analgestiques et anti-inflammatoires

Country Status (15)

Country Link
JP (3) JPS59501460A (xx)
AT (2) AT389226B (xx)
AU (1) AU558485B2 (xx)
BE (1) BE897356A (xx)
CA (1) CA1217429A (xx)
CH (1) CH659391A5 (xx)
DE (1) DE3390116C2 (xx)
FR (1) FR2530469A1 (xx)
GB (1) GB2134786B (xx)
IE (1) IE55367B1 (xx)
IT (1) IT1206502B (xx)
NL (1) NL191432C (xx)
SE (1) SE466481B (xx)
WO (1) WO1984000488A1 (xx)
ZA (2) ZA835324B (xx)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3490583T1 (de) * 1983-12-12 1986-04-03 Richardson-Vicks Inc., Wilton, Conn. Analgetische und anti-inflammatorische Mittel und Verfahren zu ihrer Verwendung
EP0167566A4 (en) * 1983-12-12 1987-06-29 Abraham Sunshine ANALGESIC AND ANTI-IGNITION COMPOSITIONS CONTAINING XANTHINE AND METHOD FOR THE USE THEREOF.

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
CH669523A5 (xx) * 1986-06-25 1989-03-31 Mepha Ag
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
CN1551770A (zh) 2001-07-06 2004-12-01 ������ҩ�����޹�˾ 羟吗啡酮控释制剂
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US7914831B2 (en) * 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
JP2006282644A (ja) * 2005-04-05 2006-10-19 Idemitsu Kosan Co Ltd 疲労回復剤
TW201247195A (en) * 2011-04-28 2012-12-01 Kowa Co Stable pharmaceutical composition
JP7523879B2 (ja) * 2016-10-31 2024-07-29 エスエス製薬株式会社 医薬組成物
JP2021054728A (ja) * 2019-09-27 2021-04-08 興和株式会社 医薬品
JP6811453B1 (ja) * 2020-06-24 2021-01-13 医療法人すぎやま内科 経皮吸収用組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439094A (en) * 1967-07-20 1969-04-15 Warner Lambert Pharmaceutical Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin
JPS5423132A (en) * 1977-07-19 1979-02-21 Dai Ichi Seiyaku Co Ltd Analgesic composition
JPS54154416A (en) * 1978-05-26 1979-12-05 Tdk Electronics Co Ltd High dielectric constant porcelain composition
US4233316A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233317A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4234601A (en) * 1978-12-18 1980-11-18 Mcneilab, Inc. Analgesic potentiation
US4233314A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233315A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4237140A (en) * 1979-05-18 1980-12-02 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetaminophen
US4315936A (en) * 1979-12-17 1982-02-16 Ortho Pharmaceutical Corporation Analgesic composition
JPS56154416A (en) * 1980-04-30 1981-11-30 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3490583T1 (de) * 1983-12-12 1986-04-03 Richardson-Vicks Inc., Wilton, Conn. Analgetische und anti-inflammatorische Mittel und Verfahren zu ihrer Verwendung
EP0167566A4 (en) * 1983-12-12 1987-06-29 Abraham Sunshine ANALGESIC AND ANTI-IGNITION COMPOSITIONS CONTAINING XANTHINE AND METHOD FOR THE USE THEREOF.

Also Published As

Publication number Publication date
SE8401538D0 (sv) 1984-03-20
GB2134786A (en) 1984-08-22
SE466481B (sv) 1992-02-24
AT389226B (de) 1989-11-10
IT8322173A0 (it) 1983-07-21
ZA835324B (en) 1984-09-26
GB2134786B (en) 1986-05-08
IE831715L (en) 1984-01-22
JPS59501459A (ja) 1984-08-16
AU558485B2 (en) 1987-01-29
ATA903983A (de) 1989-04-15
CA1217429A (en) 1987-02-03
IT1206502B (it) 1989-04-27
NL191432B (nl) 1995-03-01
GB8406704D0 (en) 1984-04-18
FR2530469A1 (fr) 1984-01-27
WO1984000488A1 (en) 1984-02-16
IE55367B1 (en) 1990-08-29
ATA245988A (de) 1989-08-15
AT389998B (de) 1990-02-26
JPH07165583A (ja) 1995-06-27
DE3390116C2 (de) 1994-06-16
NL191432C (nl) 1995-07-04
NL8320240A (nl) 1984-06-01
DE3390116T1 (de) 1985-01-10
SE8401538L (sv) 1984-03-20
AU1881683A (en) 1984-02-23
ZA835326B (en) 1984-09-26
JPS59501460A (ja) 1984-08-16
CH659391A5 (de) 1987-01-30

Similar Documents

Publication Publication Date Title
FR2559061A1 (fr) Compositions analgesiques et anti-inflammatoires contenant de la diphenhydramine
EP0114886B1 (en) Improved analgesic and anti-inflammatory compositions comprising caffeine
EP0165308B1 (en) Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
BE897356A (fr) Compositions analgestiques et anti-inflammatoires
AU569935B2 (en) Analgesic & anti-inflammatory compositions containing xanthines
EP1601349A1 (fr) UTILISATION DE L’ENANTIOMERE (1S, 2R) DU MILNACIPRAN POUR LA PREPARATION D’UN MEDICAMENT
BE897355A (fr) Compositions analgestiques et anti-inflammatoires comprenant de l'ibuprofen
US4656177A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4464376A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4777174A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4587249A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
JP2002520286A (ja) Gaba類縁体及びカフェインを含んでなる組成物
US4479956A (en) Analgesic compositions comprising propiram and methods of using same
FR2787713A1 (fr) Composition en tant que medicament et utilisation d'une telle composition pour l'obtention d'un medicament destine a l'anesthesie, notamment medicament analgesique
EP0413694A1 (fr) Preparations medicamenteuses cardio-protectrices comprenant l'amiodarone, un derive nitre, notamment le dinitrate d'isosorbide et facultativement un beta-bloqueur.
EP0004516A2 (fr) Nouvelles compositions pharmaceutiques agissant sur la motricité gastro-intestinale
EP2179734B1 (fr) Dérivés de la benzoxazine et de la dihydroquinazoline pour leur utilisation dans le traitement du syndrome de sevrage alcoolique
US20050059741A1 (en) Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-1
Jeste et al. Tardive Dyskinesia: A Review of the Treatment Possibilities